Screening and Early Treatment of Migrants for Chronic Hepatitis B Virus Infection Is Cost-Effective
- 28 February 2010
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 138 (2), 522-530
- https://doi.org/10.1053/j.gastro.2009.10.039
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screeningJournal of Hepatology, 2009
- Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis BHepatology, 2009
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapyHepatology, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- High impact of migration on the prevalence of chronic hepatitis B in the NetherlandsEuropean Journal of Gastroenterology & Hepatology, 2008
- Treatment recommendations for chronic hepatitis B: An evaluation of current guidelines based on a natural history study in the United StatesHepatology, 2008
- Underestimation of chronic hepatitis B virus infection in the United States of AmericaJournal of Viral Hepatitis, 2007
- Accuracy of a referral guideline for patients with chronic hepatitis B in primary care to select patients eligible for evaluation by a specialistGut, 2007
- Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis BPharmacoEconomics, 2007
- Referral of chronic hepatitis B patients from primary to specialist care: making a simple guideline workJournal of Hepatology, 2004